Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases

Tal H. Vishne; Ilan G. Ron

doi:10.1097/00000421-199812000-00014

Strontium-89 (⁸⁹Sr) analgesia for rare thymic carcinoid tumor with bony metastases

Tal H. Vishne, Ilan G. Ron

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The authors report the cases of two patients in whom strontium-89 (⁸⁹Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself rare and the risk of its metastasizing to the bone is very low. Both patients showed a measure of response to treatment, suggesting that this analgesic method has value for some patients. The marked benefit of one patient for a total of 9 months was attributable to two ⁸⁹Sr injections, whereas the other patient improved for only 5 weeks after one injection.

Original language	English
Pages (from-to)	602-604
Number of pages	3
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	21
Issue number	6
DOIs	https://doi.org/10.1097/00000421-199812000-00014
State	Published - Dec 1998
Externally published	Yes

Keywords

Analgesic method
Metastatic bone pain
Strontium-89
Thymic carcinoid

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00000421-199812000-00014

Cite this

@article{ba4bccbc2b1e436baaf2907604ed6284,

title = "Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases",

abstract = "The authors report the cases of two patients in whom strontium-89 (89Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself rare and the risk of its metastasizing to the bone is very low. Both patients showed a measure of response to treatment, suggesting that this analgesic method has value for some patients. The marked benefit of one patient for a total of 9 months was attributable to two 89Sr injections, whereas the other patient improved for only 5 weeks after one injection.",

keywords = "Analgesic method, Metastatic bone pain, Strontium-89, Thymic carcinoid",

author = "Vishne, {Tal H.} and Ron, {Ilan G.}",

year = "1998",

month = dec,

doi = "10.1097/00000421-199812000-00014",

language = "אנגלית",

volume = "21",

pages = "602--604",

journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases

AU - Vishne, Tal H.

AU - Ron, Ilan G.

PY - 1998/12

Y1 - 1998/12

N2 - The authors report the cases of two patients in whom strontium-89 (89Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself rare and the risk of its metastasizing to the bone is very low. Both patients showed a measure of response to treatment, suggesting that this analgesic method has value for some patients. The marked benefit of one patient for a total of 9 months was attributable to two 89Sr injections, whereas the other patient improved for only 5 weeks after one injection.

AB - The authors report the cases of two patients in whom strontium-89 (89Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself rare and the risk of its metastasizing to the bone is very low. Both patients showed a measure of response to treatment, suggesting that this analgesic method has value for some patients. The marked benefit of one patient for a total of 9 months was attributable to two 89Sr injections, whereas the other patient improved for only 5 weeks after one injection.

KW - Analgesic method

KW - Metastatic bone pain

KW - Strontium-89

KW - Thymic carcinoid

UR - http://www.scopus.com/inward/record.url?scp=0031768086&partnerID=8YFLogxK

U2 - 10.1097/00000421-199812000-00014

DO - 10.1097/00000421-199812000-00014

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 9856663

AN - SCOPUS:0031768086

SN - 0277-3732

VL - 21

SP - 602

EP - 604

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

IS - 6

ER -